IBEX (NASDAQ:IBEX) Announces Quarterly Earnings Results

IBEX (NASDAQ:IBEX) issued its quarterly earnings results on Thursday. The company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.20, FiscalAI reports. The firm had revenue of $175.23 million during the quarter, compared to the consensus estimate of $169.31 million. IBEX had a net margin of 7.34% and a return on equity of 29.98%.

Here are the key takeaways from IBEX’s conference call:

• IBEX reported 16% revenue growth to a record $175.2 million in Q1, its seventh consecutive quarter of double-digit growth. Adjusted EBITDA rose 29% to a record $25.2 million, and adjusted EBITDA margin expanded 150 basis points to 14.4%.
• The company raised FY2027 guidance: revenue is now expected to be $720 million–$735 million, up from $700 million–$715 million, while adjusted EBITDA guidance increased to $96 million–$99 million from $90 million–$94 million. Management expects 50–70 basis points of full-year margin improvement and year-over-year EBITDA improvement in each remaining quarter, though not at Q1’s pace.
• New client wins and expansion with existing customers both supported growth: recent new-logo cohorts accounted for about 50% of Q1 revenue growth, while revenue from the top five, top 10, and top 25 clients grew 14%, 13%, and 18%, respectively. Management said client retention remains above 99%.
• IBEX said its Sierra partnership is generating demand for combined AI-agent and human-support offerings, including four AI-agent deals since the quarter and three additional verbal traditional BPO wins. In one example, an AI deployment reduced abandoned calls by more than 60% and helped IBEX win the client’s traditional call-center work.

IBEX Stock Up 15.2%

Shares of NASDAQ:IBEX traded up $6.52 during trading on Friday, hitting $49.52. The stock had a trading volume of 414,464 shares, compared to its average volume of 90,691. The company has a market capitalization of $660.60 million, a PE ratio of 15.01 and a beta of 0.74. The firm’s fifty day moving average is $43.00 and its 200 day moving average is $34.50. IBEX has a 12 month low of $25.94 and a 12 month high of $49.89.

IBEX News Summary

Here are the key news stories impacting IBEX this week:

• Positive Sentiment: IBEX raised its FY2027 revenue forecast to $720 million–$735 million, above the roughly $712.3 million consensus estimate. The company attributed the improved outlook in part to accelerating Sierra AI-agent deals. Ibex raises FY 2027 revenue outlook
• Positive Sentiment: First-quarter revenue grew 16% year over year to $175.2 million, topping the $169.3 million consensus estimate. EPS of $1.10 also beat the $0.90 estimate, indicating stronger-than-expected performance. IBEX: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Wall Street Zen upgraded IBEX, adding a favorable analyst-rating signal, though the article listing did not specify the new rating. IBEX upgraded at Wall Street Zen
• Positive Sentiment: A Barron’s investor-community post highlighted IBEX reaching a new 52-week high and its AI-powered call-center business, reflecting positive market attention; this is commentary rather than a formal company announcement. A new 52-high in this market!? IBEX

Insider Activity

In other news, Director Mingzhe Zhuang sold 5,522 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $40.10, for a total value of $221,432.20. Following the transaction, the director owned 2,813 shares in the company, valued at approximately $112,801.30. This represents a 66.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Julie Casteel sold 17,474 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $40.41, for a total transaction of $706,124.34. Following the completion of the sale, the insider owned 100,814 shares in the company, valued at $4,073,893.74. This represents a 14.77% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 97,465 shares of company stock valued at $3,882,291. 3.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently issued reports on IBEX. Robert W. Baird upped their target price on IBEX from $40.00 to $44.00 and gave the stock a “neutral” rating in a report on Monday, September 28th. Weiss Ratings raised IBEX from a “buy (b-)” rating to a “buy (b)” rating in a report on Monday, October 12th. Finally, Wall Street Zen upgraded IBEX from a “buy” rating to a “strong-buy” rating in a report on Saturday. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $42.00.

About IBEX

IBEX Limited (NASDAQ: IBEX) is a business process outsourcing and customer experience technology company. It provides customer service, technical support, sales, back-office processing and other digital services for businesses across industries, including communications, healthcare, retail, logistics and financial services.

The company combines customer contact centers, digital engagement channels, analytics and artificial intelligence-enabled tools to help clients manage customer interactions and improve operational efficiency.